These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38213063)

  • 1. Characterization of Demographical Histologic Diversity in Small Renal Masses With the Clear Cell Likelihood Score.
    Vazquez LC; Xi Y; Rasmussen RG; Venzor JER; Kapur P; Zhong H; Dai JC; Morgan TN; Cadeddu JA; Pedrosa I
    J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):370-377. PubMed ID: 38213063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.
    Rasmussen RG; Xi Y; Sibley RC; Lee CJ; Cadeddu JA; Pedrosa I
    AJR Am J Roentgenol; 2022 Jan; 218(1):101-110. PubMed ID: 34286596
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses.
    Schieda N; Davenport MS; Silverman SG; Bagga B; Barkmeier D; Blank Z; Curci NE; Doshi AM; Downey RT; Edney E; Granader E; Gujrathi I; Hibbert RM; Hindman N; Walsh C; Ramsay T; Shinagare AB; Pedrosa I
    Radiology; 2022 Jun; 303(3):590-599. PubMed ID: 35289659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance and Interreader Agreement of the MRI Clear Cell Likelihood Score for Characterization of cT1a and cT1b Solid Renal Masses: An External Validation Study.
    Dunn M; Linehan V; Clarke SE; Keough V; Nelson R; Costa AF
    AJR Am J Roentgenol; 2022 Nov; 219(5):793-803. PubMed ID: 35642765
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
    Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
    Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score.
    Hao YW; Zhang Y; Guo HP; Xu W; Bai X; Zhao J; Ding XH; Gao S; Cui MQ; Liu BC; Ye HY; Wang HY
    Abdom Radiol (NY); 2023 Dec; 48(12):3714-3727. PubMed ID: 37747536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.
    Steinberg RL; Rasmussen RG; Johnson BA; Ghandour R; De Leon AD; Xi Y; Yokoo T; Kim S; Kapur P; Cadeddu JA; Pedrosa I
    Eur Radiol; 2021 Jan; 31(1):314-324. PubMed ID: 32770377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Clear Cell Likelihood Score v1.0 and v2.0 for Common Subtypes of Small Renal Masses: A Multicenter Comparative Study.
    Hao YW; Ning XY; Wang H; Bai X; Zhao J; Xu W; Zhang XJ; Yang DW; Jiang JH; Ding XH; Cui MQ; Liu BC; Guo HP; Ye HY; Wang HY
    J Magn Reson Imaging; 2025 Jan; 61(1):97-110. PubMed ID: 38738786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of clear cell likelihood scores in characterizing solid renal masses at multiparametric MRI: an external validation study.
    Ibrahim A; Pelsser V; Anidjar M; Kaitoukov Y; Camlioglu E; Moosavi B
    Abdom Radiol (NY); 2023 Mar; 48(3):1033-1043. PubMed ID: 36639532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of diagnostic performance of Clear Cell Likelihood Score v1.0 and v2.0 for clear renal cell carcinoma].
    Hao Y; Gao S; Zhang X; Cui M; Ding X; Wang H; Yang D; Ye H; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):800-806. PubMed ID: 37313822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there enough evidence supporting the clinical adoption of clear cell likelihood score (ccLS)? An updated systematic review and meta-analysis.
    Zhong J; Hu Y; Xing Y; Liu X; Ge X; Wang Y; Shi Y; Lu J; Yang J; Song Y; Lu M; Chu J; Zhang H; Ding D; Yao W
    Insights Imaging; 2024 Oct; 15(1):242. PubMed ID: 39382764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of the Clear Cell Likelihood Score and selected MRI parameters in the characterization of indeterminate renal masses - a single-institution study.
    Blachura T; Matusik PS; Kowal A; Radzikowska J; Jarczewski JD; Skiba Ł; Popiela TJ; Chrzan R
    Abdom Radiol (NY); 2024 Nov; 49(11):3893-3901. PubMed ID: 38980404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses.
    Canvasser NE; Kay FU; Xi Y; Pinho DF; Costa D; de Leon AD; Khatri G; Leyendecker JR; Yokoo T; Lay A; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
    J Urol; 2017 Oct; 198(4):780-786. PubMed ID: 28457802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
    Finelli A; Cheung DC; Al-Matar A; Evans AJ; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chin JL; Fleshner NE; Haider MA; Kachura JR; Sykes J; Jewett MAS
    Eur Urol; 2020 Sep; 78(3):460-467. PubMed ID: 32680677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide.
    Shetty AS; Fraum TJ; Ballard DH; Hoegger MJ; Itani M; Rajput MZ; Lanier MH; Cusworth BM; Mehrsheikh AL; Cabrera-Lebron JA; Chu J; Cunningham CR; Hirschi RS; Mokkarala M; Unteriner JG; Kim EH; Siegel CL; Ludwig DR
    Radiographics; 2023 Jul; 43(7):e220209. PubMed ID: 37319026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of clear cell likelihood score in differentiation between renal oncocytoma and clear cell renal cell carcinoma].
    Cui MQ; He B; Xu W; Hao YW; Ding XH; Wang S; Bai X; Liu BC; Ye HY; Wang HY
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3779-3785. PubMed ID: 36517429
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma.
    Moriyama S; Yoshida S; Tanaka H; Tanaka H; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Kihara K; Fujii Y
    Int J Urol; 2018 Jun; 25(6):554-560. PubMed ID: 29577440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a multiparametric renal CT algorithm for diagnosis of clear-cell renal cell carcinoma among small (≤ 4 cm) solid renal masses.
    Eldihimi F; Walsh C; Hibbert RM; Nasibi KA; Pickovsky JS; Schieda N
    Eur Radiol; 2024 Jun; 34(6):3992-4000. PubMed ID: 37968475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.